ID   TCPD_HUMAN              Reviewed;         539 AA.
AC   P50991; B2R6I3; B7Z8B1; F5H5W3; O14870; Q53QP9; Q96C51;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-JAN-2026, entry version 222.
DE   RecName: Full=T-complex protein 1 subunit delta;
DE            Short=TCP-1-delta;
DE            EC=3.6.1.- {ECO:0000269|PubMed:23612981};
DE   AltName: Full=CCT-delta;
DE   AltName: Full=Chaperonin containing T-complex polypeptide 1 subunit 4;
DE   AltName: Full=Stimulator of TAR RNA-binding;
GN   Name=CCT4; Synonyms=CCTD, SRB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=8626763; DOI=10.1074/jbc.271.8.4201;
RA   Wu-Baer F., Lane W.S., Gaynor R.B.;
RT   "Identification of a group of cellular cofactors that stimulate the binding
RT   of RNA polymerase II and TRP-185 to human immunodeficiency virus 1 TAR
RT   RNA.";
RL   J. Biol. Chem. 271:4201-4208(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9819444; DOI=10.1128/mcb.18.12.7584;
RA   Won K.-A., Schumacher R.J., Farr G.W., Horwich A.L., Reed S.I.;
RT   "Maturation of human cyclin E requires the function of eukaryotic
RT   chaperonin CCT.";
RL   Mol. Cell. Biol. 18:7584-7589(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-8.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 420-435, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V., Barblan J., Quadroni M.;
RL   Submitted (MAR-2004) to UniProtKB.
RN   [8]
RP   INTERACTION WITH PACRG.
RX   PubMed=14532270; DOI=10.1074/jbc.m309655200;
RA   Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R.;
RT   "A product of the human gene adjacent to parkin is a component of Lewy
RT   bodies and suppresses Pael receptor-induced cell death.";
RL   J. Biol. Chem. 278:51901-51910(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [10]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-288; LYS-302; LYS-319 AND
RP   LYS-326, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE
RP   CHAPERONIN-CONTAINING T-COMPLEX.
RX   PubMed=20080638; DOI=10.1073/pnas.0910268107;
RA   Seo S., Baye L.M., Schulz N.P., Beck J.S., Zhang Q., Slusarski D.C.,
RA   Sheffield V.C.;
RT   "BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and
RT   mediate BBSome assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:1488-1493(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   CATALYTIC ACTIVITY.
RX   PubMed=23612981; DOI=10.1074/jbc.m112.443929;
RA   Sergeeva O.A., Chen B., Haase-Pettingell C., Ludtke S.J., Chiu W.,
RA   King J.A.;
RT   "Human CCT4 and CCT5 chaperonin subunits expressed in Escherichia coli form
RT   biologically active homo-oligomers.";
RL   J. Biol. Chem. 288:17734-17744(2013).
RN   [16]
RP   FUNCTION, AND IDENTIFICATION IN THE CHAPERONIN-CONTAINING T-COMPLEX.
RX   PubMed=25467444; DOI=10.1016/j.cell.2014.10.059;
RA   Freund A., Zhong F.L., Venteicher A.S., Meng Z., Veenstra T.D., Frydman J.,
RA   Artandi S.E.;
RT   "Proteostatic control of telomerase function through TRiC-mediated folding
RT   of TCAB1.";
RL   Cell 159:1389-1403(2014).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-184; SER-202 AND
RP   SER-444, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-19, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   INTERACTION WITH DLEC1.
RX   PubMed=33144677; DOI=10.1038/s41598-020-75957-y;
RA   Okitsu Y., Nagano M., Yamagata T., Ito C., Toshimori K., Dohra H.,
RA   Fujii W., Yogo K.;
RT   "Dlec1 is required for spermatogenesis and male fertility in mice.";
RL   Sci. Rep. 10:18883-18883(2020).
RN   [22] {ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB, ECO:0007744|PDB:7WU7}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS) IN COMPLEX WITH TUBULIN,
RP   FUNCTION, SUBUNIT, AND ADP AND MG(2+) BINDING SITES.
RX   PubMed=36493755; DOI=10.1016/j.cell.2022.11.014;
RA   Gestaut D., Zhao Y., Park J., Ma B., Leitner A., Collier M., Pintilie G.,
RA   Roh S.H., Chiu W., Frydman J.;
RT   "Structural visualization of the tubulin folding pathway directed by human
RT   chaperonin TRiC/CCT.";
RL   Cell 185:4770-4787.e20(2022).
RN   [23] {ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7NVO}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.50 ANGSTROMS) IN COMPLEX WITH TUBULIN
RP   AND IN COMPLEX WITH ACTIN, FUNCTION, SUBUNIT, AND ADP AND MG(2+) BINDING
RP   SITES.
RX   PubMed=35449234; DOI=10.1038/s41594-022-00755-1;
RA   Kelly J.J., Tranter D., Pardon E., Chi G., Kramer H., Happonen L.,
RA   Knee K.M., Janz J.M., Steyaert J., Bulawa C., Paavilainen V.O.,
RA   Huiskonen J.T., Yue W.W.;
RT   "Snapshots of actin and tubulin folding inside the TRiC chaperonin.";
RL   Nat. Struct. Mol. Biol. 29:420-429(2022).
RN   [24] {ECO:0007744|PDB:7WZ3, ECO:0007744|PDB:7X0A, ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V, ECO:0007744|PDB:7X3J, ECO:0007744|PDB:7X3U, ECO:0007744|PDB:7X6Q, ECO:0007744|PDB:7X7Y}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.10 ANGSTROMS) IN COMPLEX WITH TUBULIN,
RP   FUNCTION, SUBUNIT, AND ATP; ADP AND MG(2+) BINDING SITES.
RX   PubMed=37193829; DOI=10.1038/s42003-023-04915-x;
RA   Liu C., Jin M., Wang S., Han W., Zhao Q., Wang Y., Xu C., Diao L., Yin Y.,
RA   Peng C., Peng C., Bao L., Wang Y., Cong Y.;
RT   "Pathway and mechanism of tubulin folding mediated by TRiC/CCT along its
RT   ATPase cycle revealed using cryo-EM.";
RL   Commun. Biol. 6:531-531(2023).
RN   [25]
RP   INVOLVEMENT IN BRAIN DEVELOPMENTAL DISORDERS.
RX   PubMed=39480921; DOI=10.1126/science.adp8721;
RA   Kraft F., Rodriguez-Aliaga P., Yuan W., Franken L., Zajt K., Hasan D.,
RA   Lee T.T., Flex E., Hentschel A., Innes A.M., Zheng B., Julia Suh D.S.,
RA   Knopp C., Lausberg E., Krause J., Zhang X., Trapane P., Carroll R.,
RA   McClatchey M., Fry A.E., Wang L., Giesselmann S., Hoang H., Baldridge D.,
RA   Silverman G.A., Radio F.C., Bertini E., Ciolfi A., Blood K.A.,
RA   de Sainte Agathe J.M., Charles P., Bergant G., Cuturilo G., Peterlin B.,
RA   Diderich K., Streff H., Robak L., Oegema R., van Binsbergen E.,
RA   Herriges J., Saunders C.J., Maier A., Wolking S., Weber Y., Lochmueller H.,
RA   Meyer S., Aleman A., Polavarapu K., Nicolas G., Goldenberg A., Guyant L.,
RA   Pope K., Hehmeyer K.N., Monaghan K.G., Quade A., Smol T., Caumes R.,
RA   Duerinckx S., Depondt C., Van Paesschen W., Rieubland C., Poloni C.,
RA   Guipponi M., Arcioni S., Meuwissen M., Jansen A.C., Rosenblum J.,
RA   Haack T.B., Bertrand M., Gerstner L., Magg J., Riess O., Schulz J.B.,
RA   Wagner N., Wiesmann M., Weis J., Eggermann T., Begemann M., Roos A.,
RA   Haeusler M., Schedl T., Tartaglia M., Bremer J., Pak S.C., Frydman J.,
RA   Elbracht M., Kurth I.;
RT   "Brain malformations and seizures by impaired chaperonin function of
RT   TRiC.";
RL   Science 386:516-525(2024).
CC   -!- FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a
CC       molecular chaperone complex that assists the folding of actin, tubulin
CC       and other proteins upon ATP hydrolysis (PubMed:25467444,
CC       PubMed:36493755, PubMed:35449234, PubMed:37193829). The TRiC complex
CC       mediates the folding of WRAP53/TCAB1, thereby regulating telomere
CC       maintenance (PubMed:25467444). As part of the TRiC complex may play a
CC       role in the assembly of BBSome, a complex involved in ciliogenesis
CC       regulating transports vesicles to the cilia (PubMed:20080638).
CC       {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444,
CC       ECO:0000269|PubMed:35449234, ECO:0000269|PubMed:36493755,
CC       ECO:0000269|PubMed:37193829}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:23612981};
CC   -!- SUBUNIT: Component of the chaperonin-containing T-complex (TRiC), a
CC       hexadecamer composed of two identical back-to-back stacked rings
CC       enclosing a protein folding chamber (PubMed:20080638, PubMed:25467444,
CC       PubMed:36493755, PubMed:35449234, PubMed:37193829). Each ring is made
CC       up of eight different subunits: TCP1/CCT1, CCT2, CCT3, CCT4, CCT5,
CC       CCT6A/CCT6, CCT7, CCT8 (PubMed:36493755, PubMed:35449234,
CC       PubMed:37193829). Interacts with PACRG (PubMed:14532270). Interacts
CC       with DNAAF4 (By similarity). Interacts with DLEC1 (PubMed:33144677).
CC       {ECO:0000250|UniProtKB:P80315, ECO:0000269|PubMed:14532270,
CC       ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444,
CC       ECO:0000269|PubMed:33144677, ECO:0000269|PubMed:35449234,
CC       ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829}.
CC   -!- INTERACTION:
CC       P50991; P51946: CCNH; NbExp=3; IntAct=EBI-356876, EBI-741406;
CC       P50991; P78371: CCT2; NbExp=9; IntAct=EBI-356876, EBI-357407;
CC       P50991; Q99759: MAP3K3; NbExp=2; IntAct=EBI-356876, EBI-307281;
CC       P50991; P78380: OLR1; NbExp=3; IntAct=EBI-356876, EBI-7151999;
CC       P50991; P17987: TCP1; NbExp=3; IntAct=EBI-356876, EBI-356553;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17081065,
CC       ECO:0000269|PubMed:20080638}. Melanosome {ECO:0000269|PubMed:17081065}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:14654843, ECO:0000269|PubMed:20080638}. Cytoplasm,
CC       cytoskeleton, cilium basal body {ECO:0000250|UniProtKB:P80315}.
CC       Note=Identified by mass spectrometry in melanosome fractions from stage
CC       I to stage IV. {ECO:0000269|PubMed:17081065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50991-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50991-2; Sequence=VSP_045537;
CC   -!- DISEASE: Note=De novo genetic variants in nearly every subunit of the
CC       TRiC complex, including CCT4, have been found in individuals with a
CC       broad spectrum of brain malformations, and clinical phenotypes ranging
CC       from mild to severe epilepsy, developmental delay, intellectual
CC       disability, ataxia, and other features of cerebral malfunction.
CC       {ECO:0000269|PubMed:39480921}.
CC   -!- SIMILARITY: Belongs to the TCP-1 chaperonin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U38846; AAC50384.1; -; mRNA.
DR   EMBL; AF026291; AAC96010.1; -; mRNA.
DR   EMBL; AK303082; BAH13897.1; -; mRNA.
DR   EMBL; AK312586; BAG35480.1; -; mRNA.
DR   EMBL; AC107081; AAY24140.1; -; Genomic_DNA.
DR   EMBL; BC014676; AAH14676.1; -; mRNA.
DR   EMBL; BC106934; AAI06935.1; -; mRNA.
DR   EMBL; BC106933; AAI06934.1; -; mRNA.
DR   CCDS; CCDS33206.1; -. [P50991-1]
DR   CCDS; CCDS58711.1; -. [P50991-2]
DR   RefSeq; NP_001243650.1; NM_001256721.1. [P50991-2]
DR   RefSeq; NP_006421.2; NM_006430.3. [P50991-1]
DR   PDB; 6NR8; EM; 7.80 A; D/L=26-539.
DR   PDB; 6NR9; EM; 8.50 A; D/L=26-539.
DR   PDB; 6NRA; EM; 7.70 A; D/L=26-539.
DR   PDB; 6NRB; EM; 8.70 A; D/L=26-539.
DR   PDB; 6NRC; EM; 8.30 A; D/L=26-539.
DR   PDB; 6NRD; EM; 8.20 A; D/L=26-539.
DR   PDB; 6QB8; EM; 3.97 A; D/d=1-539.
DR   PDB; 7LUM; EM; 4.50 A; F/N=1-539.
DR   PDB; 7LUP; EM; 6.20 A; F/N=1-539.
DR   PDB; 7NVL; EM; 2.50 A; D/d=1-539.
DR   PDB; 7NVM; EM; 3.10 A; D/d=1-539.
DR   PDB; 7NVN; EM; 3.00 A; D/d=1-539.
DR   PDB; 7NVO; EM; 3.50 A; D/d=1-539.
DR   PDB; 7TRG; EM; 3.00 A; F=1-539.
DR   PDB; 7TTN; EM; 3.30 A; F=1-539.
DR   PDB; 7TTT; EM; 2.90 A; F=1-539.
DR   PDB; 7TUB; EM; 3.60 A; F=1-539.
DR   PDB; 7WU7; EM; 3.85 A; D/L=1-539.
DR   PDB; 7WZ3; EM; 4.10 A; D/d=1-539.
DR   PDB; 7X0A; EM; 3.10 A; D/d=1-539.
DR   PDB; 7X0S; EM; 3.10 A; I/M=1-539.
DR   PDB; 7X0V; EM; 3.20 A; I/M=1-539.
DR   PDB; 7X3J; EM; 4.20 A; D/d=1-539.
DR   PDB; 7X3U; EM; 3.30 A; D/d=1-539.
DR   PDB; 7X6Q; EM; 4.50 A; I/M=1-539.
DR   PDB; 7X7Y; EM; 3.80 A; D/d=1-539.
DR   PDB; 8HKI; EM; 3.10 A; D/d=1-539.
DR   PDB; 8I1U; EM; 3.24 A; D/L=1-539.
DR   PDB; 8I9Q; EM; 4.22 A; D=1-539.
DR   PDB; 8I9U; EM; 3.10 A; D/L=1-539.
DR   PDB; 8IB8; EM; 4.42 A; D/L=1-539.
DR   PDB; 8SFE; EM; 3.36 A; D/d=19-539.
DR   PDB; 8SFF; EM; 3.20 A; D/d=19-538.
DR   PDB; 8SG8; EM; 3.00 A; D/d=19-538.
DR   PDB; 8SG9; EM; 2.90 A; D/d=19-538.
DR   PDB; 8SGC; EM; 2.90 A; D/d=19-538.
DR   PDB; 8SGL; EM; 2.90 A; D/d=19-538.
DR   PDB; 8SGQ; EM; 3.70 A; D/d=19-538.
DR   PDB; 8SH9; EM; 2.70 A; D/d=19-538.
DR   PDB; 8SHA; EM; 3.00 A; D/d=19-538.
DR   PDB; 8SHD; EM; 2.90 A; D/d=19-538.
DR   PDB; 8SHE; EM; 2.80 A; D/d=19-538.
DR   PDB; 8SHF; EM; 3.00 A; D/d=19-538.
DR   PDB; 8SHG; EM; 2.80 A; D/d=19-538.
DR   PDB; 8SHL; EM; 3.00 A; D/d=19-538.
DR   PDB; 8SHN; EM; 2.80 A; D/d=19-538.
DR   PDB; 8SHO; EM; 3.00 A; D/d=19-538.
DR   PDB; 8SHP; EM; 3.00 A; D/d=19-538.
DR   PDB; 8SHQ; EM; 2.90 A; D/d=19-538.
DR   PDB; 8SHT; EM; 3.00 A; D/d=19-538.
DR   PDBsum; 6NR8; -.
DR   PDBsum; 6NR9; -.
DR   PDBsum; 6NRA; -.
DR   PDBsum; 6NRB; -.
DR   PDBsum; 6NRC; -.
DR   PDBsum; 6NRD; -.
DR   PDBsum; 6QB8; -.
DR   PDBsum; 7LUM; -.
DR   PDBsum; 7LUP; -.
DR   PDBsum; 7NVL; -.
DR   PDBsum; 7NVM; -.
DR   PDBsum; 7NVN; -.
DR   PDBsum; 7NVO; -.
DR   PDBsum; 7TRG; -.
DR   PDBsum; 7TTN; -.
DR   PDBsum; 7TTT; -.
DR   PDBsum; 7TUB; -.
DR   PDBsum; 7WU7; -.
DR   PDBsum; 7WZ3; -.
DR   PDBsum; 7X0A; -.
DR   PDBsum; 7X0S; -.
DR   PDBsum; 7X0V; -.
DR   PDBsum; 7X3J; -.
DR   PDBsum; 7X3U; -.
DR   PDBsum; 7X6Q; -.
DR   PDBsum; 7X7Y; -.
DR   PDBsum; 8HKI; -.
DR   PDBsum; 8I1U; -.
DR   PDBsum; 8I9Q; -.
DR   PDBsum; 8I9U; -.
DR   PDBsum; 8IB8; -.
DR   PDBsum; 8SFE; -.
DR   PDBsum; 8SFF; -.
DR   PDBsum; 8SG8; -.
DR   PDBsum; 8SG9; -.
DR   PDBsum; 8SGC; -.
DR   PDBsum; 8SGL; -.
DR   PDBsum; 8SGQ; -.
DR   PDBsum; 8SH9; -.
DR   PDBsum; 8SHA; -.
DR   PDBsum; 8SHD; -.
DR   PDBsum; 8SHE; -.
DR   PDBsum; 8SHF; -.
DR   PDBsum; 8SHG; -.
DR   PDBsum; 8SHL; -.
DR   PDBsum; 8SHN; -.
DR   PDBsum; 8SHO; -.
DR   PDBsum; 8SHP; -.
DR   PDBsum; 8SHQ; -.
DR   PDBsum; 8SHT; -.
DR   AlphaFoldDB; P50991; -.
DR   EMDB; EMD-0490; -.
DR   EMDB; EMD-0491; -.
DR   EMDB; EMD-0492; -.
DR   EMDB; EMD-0493; -.
DR   EMDB; EMD-0494; -.
DR   EMDB; EMD-0495; -.
DR   EMDB; EMD-12605; -.
DR   EMDB; EMD-12606; -.
DR   EMDB; EMD-12607; -.
DR   EMDB; EMD-12608; -.
DR   EMDB; EMD-13754; -.
DR   EMDB; EMD-23522; -.
DR   EMDB; EMD-23526; -.
DR   EMDB; EMD-26089; -.
DR   EMDB; EMD-26120; -.
DR   EMDB; EMD-26123; -.
DR   EMDB; EMD-26131; -.
DR   EMDB; EMD-32823; -.
DR   EMDB; EMD-32903; -.
DR   EMDB; EMD-32922; -.
DR   EMDB; EMD-32923; -.
DR   EMDB; EMD-32926; -.
DR   EMDB; EMD-32989; -.
DR   EMDB; EMD-32993; -.
DR   EMDB; EMD-33025; -.
DR   EMDB; EMD-33053; -.
DR   EMDB; EMD-34852; -.
DR   EMDB; EMD-35122; -.
DR   EMDB; EMD-35280; -.
DR   EMDB; EMD-35284; -.
DR   EMDB; EMD-35335; -.
DR   EMDB; EMD-40439; -.
DR   EMDB; EMD-40440; -.
DR   EMDB; EMD-40452; -.
DR   EMDB; EMD-40453; -.
DR   EMDB; EMD-40454; -.
DR   EMDB; EMD-40461; -.
DR   EMDB; EMD-40464; -.
DR   EMDB; EMD-40481; -.
DR   EMDB; EMD-40482; -.
DR   EMDB; EMD-40484; -.
DR   EMDB; EMD-40485; -.
DR   EMDB; EMD-40486; -.
DR   EMDB; EMD-40487; -.
DR   EMDB; EMD-40488; -.
DR   EMDB; EMD-40489; -.
DR   EMDB; EMD-40490; -.
DR   EMDB; EMD-40491; -.
DR   EMDB; EMD-40492; -.
DR   EMDB; EMD-40494; -.
DR   EMDB; EMD-4489; -.
DR   SMR; P50991; -.
DR   BioGRID; 115826; 599.
DR   ComplexPortal; CPX-6030; Chaperonin-containing T-complex.
DR   CORUM; P50991; -.
DR   DIP; DIP-32971N; -.
DR   FunCoup; P50991; 4398.
DR   IntAct; P50991; 301.
DR   MINT; P50991; -.
DR   STRING; 9606.ENSP00000377958; -.
DR   TCDB; 3.A.33.1.1; the bbsome complex (bbsome) family.
DR   GlyCosmos; P50991; 1 site, 1 glycan.
DR   GlyGen; P50991; 4 sites, 1 O-linked glycan (4 sites).
DR   iPTMnet; P50991; -.
DR   MetOSite; P50991; -.
DR   PhosphoSitePlus; P50991; -.
DR   SwissPalm; P50991; -.
DR   BioMuta; CCT4; -.
DR   DMDM; 52001478; -.
DR   REPRODUCTION-2DPAGE; IPI00302927; -.
DR   jPOST; P50991; -.
DR   MassIVE; P50991; -.
DR   PaxDb; 9606-ENSP00000377958; -.
DR   PeptideAtlas; P50991; -.
DR   ProteomicsDB; 27004; -.
DR   ProteomicsDB; 56273; -. [P50991-1]
DR   Pumba; P50991; -.
DR   TopDownProteomics; P50991-1; -. [P50991-1]
DR   Antibodypedia; 15920; 275 antibodies from 32 providers.
DR   DNASU; 10575; -.
DR   Ensembl; ENST00000394440.8; ENSP00000377958.3; ENSG00000115484.16. [P50991-1]
DR   Ensembl; ENST00000544079.2; ENSP00000443061.1; ENSG00000115484.16. [P50991-2]
DR   GeneID; 10575; -.
DR   KEGG; hsa:10575; -.
DR   MANE-Select; ENST00000394440.8; ENSP00000377958.3; NM_006430.4; NP_006421.2.
DR   UCSC; uc002sbo.5; human. [P50991-1]
DR   AGR; HGNC:1617; -.
DR   ClinPGx; PA26181; -.
DR   CTD; 10575; -.
DR   DisGeNET; 10575; -.
DR   GeneCards; CCT4; -.
DR   HGNC; HGNC:1617; CCT4.
DR   HPA; ENSG00000115484; Low tissue specificity.
DR   MIM; 605142; gene.
DR   OpenTargets; ENSG00000115484; -.
DR   VEuPathDB; HostDB:ENSG00000115484; -.
DR   eggNOG; KOG0358; Eukaryota.
DR   GeneTree; ENSGT00550000074956; -.
DR   HOGENOM; CLU_008891_9_1_1; -.
DR   InParanoid; P50991; -.
DR   OMA; HPAANMI; -.
DR   OrthoDB; 10248520at2759; -.
DR   PAN-GO; P50991; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; P50991; -.
DR   BRENDA; 3.6.4.B10; 2681.
DR   PathwayCommons; P50991; -.
DR   Reactome; R-HSA-389957; Prefoldin mediated transfer of substrate to CCT/TriC.
DR   Reactome; R-HSA-389960; Formation of tubulin folding intermediates by CCT/TriC.
DR   Reactome; R-HSA-390450; Folding of actin by CCT/TriC.
DR   Reactome; R-HSA-390471; Association of TriC/CCT with target proteins during biosynthesis.
DR   Reactome; R-HSA-5620922; BBSome-mediated cargo-targeting to cilium.
DR   Reactome; R-HSA-6814122; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding.
DR   SignaLink; P50991; -.
DR   SIGNOR; P50991; -.
DR   Agora; ENSG00000115484; -.
DR   BioGRID-ORCS; 10575; 801 hits in 1163 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; CCT4; human.
DR   GeneWiki; CCT4; -.
DR   GenomeRNAi; 10575; -.
DR   Pharos; P50991; Tbio.
DR   PRO; PR:P50991; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P50991; protein.
DR   Bgee; ENSG00000115484; Expressed in primordial germ cell in gonad and 213 other cell types or tissues.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IDA:MGI.
DR   GO; GO:0005832; C:chaperonin-containing T-complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0002199; C:zona pellucida receptor complex; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0044183; F:protein folding chaperone; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IBA:GO_Central.
DR   GO; GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl.
DR   GO; GO:1904871; P:positive regulation of protein localization to Cajal body; HMP:BHF-UCL.
DR   GO; GO:1904874; P:positive regulation of telomerase RNA localization to Cajal body; IMP:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
DR   GO; GO:0006457; P:protein folding; IDA:FlyBase.
DR   GO; GO:0050821; P:protein stabilization; IMP:BHF-UCL.
DR   GO; GO:0090666; P:scaRNA localization to Cajal body; IMP:BHF-UCL.
DR   CDD; cd03338; TCP1_delta; 1.
DR   FunFam; 3.50.7.10:FF:000010; T-complex protein 1 subunit delta; 1.
DR   Gene3D; 3.50.7.10; GroEL; 1.
DR   Gene3D; 1.10.560.10; GroEL-like equatorial domain; 1.
DR   Gene3D; 3.30.260.10; TCP-1-like chaperonin intermediate domain; 1.
DR   InterPro; IPR012717; Chap_CCT_delta.
DR   InterPro; IPR017998; Chaperone_TCP-1.
DR   InterPro; IPR002194; Chaperonin_TCP-1_CS.
DR   InterPro; IPR002423; Cpn60/GroEL/TCP-1.
DR   InterPro; IPR027409; GroEL-like_apical_dom_sf.
DR   InterPro; IPR027413; GROEL-like_equatorial_sf.
DR   InterPro; IPR027410; TCP-1-like_intermed_sf.
DR   InterPro; IPR053374; TCP-1_chaperonin.
DR   InterPro; IPR054827; thermosome_alpha.
DR   NCBIfam; TIGR02342; chap_CCT_delta; 1.
DR   NCBIfam; NF041082; thermosome_alpha; 1.
DR   NCBIfam; NF041083; thermosome_beta; 1.
DR   PANTHER; PTHR11353; CHAPERONIN; 1.
DR   Pfam; PF00118; Cpn60_TCP1; 1.
DR   PRINTS; PR00304; TCOMPLEXTCP1.
DR   SUPFAM; SSF52029; GroEL apical domain-like; 1.
DR   SUPFAM; SSF48592; GroEL equatorial domain-like; 1.
DR   SUPFAM; SSF54849; GroEL-intermediate domain like; 1.
DR   PROSITE; PS00750; TCP1_1; 1.
DR   PROSITE; PS00751; TCP1_2; 1.
DR   PROSITE; PS00995; TCP1_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell projection; Chaperone; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Hydrolase; Methylation; Nucleotide-binding;
KW   Phosphoprotein; Proteomics identification; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12665801"
FT   CHAIN           2..539
FT                   /note="T-complex protein 1 subunit delta"
FT                   /id="PRO_0000128332"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         53
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7NVO, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7TUB"
FT   BINDING         53
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         104
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7NVO, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7TUB, ECO:0007744|PDB:7X0S,
FT                   ECO:0007744|PDB:7X0V"
FT   BINDING         105
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TUB"
FT   BINDING         105
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         106
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:37193829, ECO:0007744|PDB:7NVO,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V"
FT   BINDING         106
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         107
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7TUB, ECO:0007744|PDB:7X0S,
FT                   ECO:0007744|PDB:7X0V, ECO:0007744|PDB:7X3U"
FT   BINDING         108
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7NVM, ECO:0007744|PDB:7NVN,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN,
FT                   ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB"
FT   BINDING         172
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V"
FT   BINDING         173
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7TRG,
FT                   ECO:0007744|PDB:7TTN, ECO:0007744|PDB:7TTT,
FT                   ECO:0007744|PDB:7TUB"
FT   BINDING         174
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:37193829, ECO:0007744|PDB:7NVL,
FT                   ECO:0007744|PDB:7X3U"
FT   BINDING         174
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7X3J"
FT   BINDING         425
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:35449234,
FT                   ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829,
FT                   ECO:0007744|PDB:7NVL, ECO:0007744|PDB:7NVM,
FT                   ECO:0007744|PDB:7NVN, ECO:0007744|PDB:7NVO,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN,
FT                   ECO:0007744|PDB:7TTT, ECO:0007744|PDB:7TUB,
FT                   ECO:0007744|PDB:7X0S, ECO:0007744|PDB:7X0V,
FT                   ECO:0007744|PDB:7X3U"
FT   BINDING         510
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000269|PubMed:36493755,
FT                   ECO:0007744|PDB:7TRG, ECO:0007744|PDB:7TTN"
FT   MOD_RES         19
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P80315"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         184
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         288
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         302
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         319
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         326
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         444
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         60..89
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045537"
FT   VARIANT         112
FT                   /note="I -> V (in dbSNP:rs2272428)"
FT                   /id="VAR_052266"
FT   CONFLICT        435
FT                   /note="R -> A (in Ref. 1; AAC50384)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        531
FT                   /note="K -> R (in Ref. 3; BAH13897)"
FT                   /evidence="ECO:0000305"
FT   HELIX           29..48
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           49..51
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          58..62
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          64..66
FT                   /evidence="ECO:0007829|PDB:7TTT"
FT   STRAND          68..71
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           74..80
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           86..101
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           108..126
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           130..151
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          152..154
FT                   /evidence="ECO:0007829|PDB:7X0A"
FT   HELIX           160..171
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          172..175
FT                   /evidence="ECO:0007829|PDB:8SG9"
FT   TURN            176..179
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           180..193
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            197..199
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           205..207
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          208..212
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          214..216
FT                   /evidence="ECO:0007829|PDB:7X0A"
FT   HELIX           218..220
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          222..229
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          234..237
FT                   /evidence="ECO:0007829|PDB:8SH9"
FT   STRAND          240..249
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          253..255
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          259..261
FT                   /evidence="ECO:0007829|PDB:7X0A"
FT   STRAND          262..266
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           269..291
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            292..294
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          297..301
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          304..306
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           311..319
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          323..328
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           330..332
FT                   /evidence="ECO:0007829|PDB:8SH9"
FT   HELIX           333..340
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          344..347
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           348..350
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           353..355
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          357..366
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          368..370
FT                   /evidence="ECO:0007829|PDB:8SHG"
FT   STRAND          372..377
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          379..381
FT                   /evidence="ECO:0007829|PDB:8SHP"
FT   STRAND          386..390
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          392..394
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           395..417
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          420..423
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           427..442
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            444..446
FT                   /evidence="ECO:0007829|PDB:8SG9"
FT   HELIX           447..458
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           460..469
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           473..486
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          491..494
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            495..498
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          499..502
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   TURN            503..507
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          509..511
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   HELIX           512..530
FT                   /evidence="ECO:0007829|PDB:7NVL"
FT   STRAND          532..535
FT                   /evidence="ECO:0007829|PDB:7NVL"
SQ   SEQUENCE   539 AA;  57924 MW;  39913C0D0735180D CRC64;
     MPENVAPRSG ATAGAAGGRG KGAYQDRDKP AQIRFSNISA AKAVADAIRT SLGPKGMDKM
     IQDGKGDVTI TNDGATILKQ MQVLHPAARM LVELSKAQDI EAGDGTTSVV IIAGSLLDSC
     TKLLQKGIHP TIISESFQKA LEKGIEILTD MSRPVELSDR ETLLNSATTS LNSKVVSQYS
     SLLSPMSVNA VMKVIDPATA TSVDLRDIKI VKKLGGTIDD CELVEGLVLT QKVSNSGITR
     VEKAKIGLIQ FCLSAPKTDM DNQIVVSDYA QMDRVLREER AYILNLVKQI KKTGCNVLLI
     QKSILRDALS DLALHFLNKM KIMVIKDIER EDIEFICKTI GTKPVAHIDQ FTADMLGSAE
     LAEEVNLNGS GKLLKITGCA SPGKTVTIVV RGSNKLVIEE AERSIHDALC VIRCLVKKRA
     LIAGGGAPEI ELALRLTEYS RTLSGMESYC VRAFADAMEV IPSTLAENAG LNPISTVTEL
     RNRHAQGEKT AGINVRKGGI SNILEELVVQ PLLVSVSALT LATETVRSIL KIDDVVNTR
//
